Zanwar, Saurabh http://orcid.org/0000-0001-5074-8453
Abeykoon, Jithma P.
Ansell, Stephen M.
Gertz, Morie A.
Dispenzieri, Angela
Muchtar, Eli http://orcid.org/0000-0003-2210-2174
Sidana, Surbhi http://orcid.org/0000-0003-3288-7614
Tandon, Nidhi http://orcid.org/0000-0003-4008-9081
Rajkumar, S. Vincent
Dingli, David
Go, Ronald http://orcid.org/0000-0002-8284-3495
Lacy, Martha Q.
Kourelis, Taxiarchis
Witzig, Thomas E.
Inwards, David
Buadi, Francis
Gonsalves, Wilson
Habermann, Thomas
Johnston, Patrick
Nowakowski, Grzegorz
Kyle, Robert A.
Kumar, Shaji http://orcid.org/0000-0001-5392-9284
Kapoor, Prashant
Article History
Received: 11 July 2018
Revised: 22 August 2018
Accepted: 24 September 2018
First Online: 12 October 2018
Compliance with ethical standards
:
: Dr. Ansell has received research funding from Bristol-Myers Squibb, Celldex, Merck, and Seattle Genetics. Dr. Dispenzieri has received research funding from Prothena, Jannsen, Pfizer, GSK, Takeda, Alnylam, Celgene, and serves on the advisory board for Takeda and Intellia. Dr. Gertz has received funding from Amgen, Prothena, Annexon, Appellis, Johnson and Johnson, and Celgene. Dr. Kumar has received research grants for clinical trials from Celgene, Takeda, Janssen, BMS, Sanofi, KITE, Merck, Abbvie, Medimmune, Novartis, Roche-Genentech, Amgen. Dr. Leung serves on the advisory board for Takeda and Prothena. Dr. Kapoor is principal investigator on studies for which Mayo Clinic receives funding from Takeda, Sanofi, and Amgen. The remaining authors declare that they have no conflicts of interest.